Denmark· DK-28105378014
Bendamustin "Actavis"
A bendamustine product containing bendamustinhydrochlorid, registered in Denmark by Actavis Group PTC ehf.. The same ATC class is registered in 17 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Bendamustine is registered in 17 of 19 countries.
Countries holding a registration under ATC L01AA09 (bendamustine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Bendamustine · ATC L01AA09
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bendamustine costs, country by country.
Normalised to the WHO defined daily dose (17 mg), the median price runs from $1.82 in Czechia to $45.03 in Switzerland — a ×25 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bendamustine · price per daily dose (17 mg)
USD · FX 28 Sept 2026
- CH Switzerland$45.03
- CZ Czechia$1.82
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Bendamustinhydrochlorid
- Manufacturer
- Actavis Group PTC ehf.
- Country
- Denmark (DK)
- ATC code
- L01AA09
- ATC class
- Bendamustine
- Defined daily dose
- 17 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105378014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
174 interactions on record for bendamustine.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bendamustine · interactions on record
174 records
- 29 severe
- 145 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01AA09
Bendamustine, as other registers publish it.
- FinlandAlkybendUAB Norameda
- United StatesBELRAPZOEagle Pharmaceuticals, Inc
- GermanyBenda NcHexal Ag
- DenmarkBendamedacMedac, Gesellschaft für klinische Spezialpräparate mbH
- SwitzerlandBendamustin Accord
- SwitzerlandBendamustin Accord
- GermanyBendamustin AccordAccord Healthcare B.V.
- SwitzerlandBendamustin Accord
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d999a9ab-27ea-4a61-ba4e-666e3c7c53f8 GET /v1/drugs/d999a9ab-27ea-4a61-ba4e-666e3c7c53f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "2,5 mg/ml",
"auth_role": "RMS",
"dk_drugid": "28105378014",
"substance": "Bendamustinhydrochlorid",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "42080"
}See everything about bendamustine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.